Brigid DeCoursey Bondoc | Partner
Morrison Foerster

Brigid DeCoursey Bondoc is a Partner at Morrison Foerster, a leading global law firm known for its expertise in life sciences. With over 15 years of experience, Brigid specializes in advising pharmaceutical and biotechnology companies on complex regulatory matters related to orphan drugs and rare diseases. Her in-depth knowledge of FDA regulations and industry practices has made her a trusted advisor to clients navigating the unique challenges of bringing orphan drugs to market.

Brigid is passionate about advocating for treatments for rare diseases and has been instrumental in helping clients secure orphan drug designations and approvals. Her strategic counsel has enabled companies to successfully launch innovative therapies that address unmet medical needs. Brigid is also actively involved in shaping orphan drug policy and regularly contributes to thought leadership initiatives in the industry.